XCR1 and neoplasm: Among the CD11b+ myeloid cells, we identified cDCs and macrophages based on known markers that have been previously identified in human tumor-infiltrating immune cells12–14, including tumor-associated dendritic cells (XCR1+ cDC1, SIRP1a+ cDC2, SiglecH+ pDC) and tumor-associated macrophages (TAMs) (Supplementary Fig. 2b).